US Stock MarketDetailed Quotes

DSGN Design Therapeutics

Watchlist

4.180
+0.020+0.48%

Trading May 23 12:17 ET

236.15MMarket Cap-4019P/E (TTM)

Design Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

28.61%-12.44M

-14.11%-58.56M

15.19%-12.8M

-4.57%-14.53M

-31.47%-13.8M

-47.32%-17.42M

-74.68%-51.32M

-63.55%-15.09M

-70.25%-13.9M

-26.67%-10.5M

Net income from continuing operations

42.44%-11.11M

-5.61%-66.86M

31.71%-11.84M

10.82%-15.79M

-32.92%-19.94M

-45.45%-19.29M

-78.17%-63.31M

-56.71%-17.34M

-56.42%-17.7M

-96.42%-15M

Depreciation and amortization

10.85%143K

32.27%537K

11.29%138K

26.85%137K

44.57%133K

57.32%129K

214.73%406K

51.22%124K

248.39%108K

666.67%92K

Other non cash items

-60.00%4K

-48.44%33K

-54.55%5K

-42.86%8K

-60.00%10K

-28.57%10K

236.84%64K

-21.43%11K

--14K

--25K

Change In working capital

-430.56%-2.93M

-63.45%728K

-3,053.97%-1.99M

-131.52%-400K

101.21%3.67M

46.67%-553K

42.69%1.99M

-139.38%-63K

-31.41%1.27M

194.46%1.82M

-Change in prepaid assets

-134.48%-411K

158.18%1.97M

274.73%823K

66.40%-639K

175.58%598K

196.36%1.19M

-233.63%-3.39M

-334.33%-471K

-508.15%-1.9M

113.36%217K

-Change in payables and accrued expense

-44.58%-2.52M

-123.14%-1.25M

-788.73%-2.81M

-92.46%239K

91.16%3.07M

-972.50%-1.75M

123.17%5.39M

1,095.12%408K

129.12%3.17M

624.84%1.61M

Cash from discontinued investing activities

Operating cash flow

28.61%-12.44M

-14.11%-58.56M

15.19%-12.8M

-4.57%-14.53M

-31.47%-13.8M

-47.32%-17.42M

-74.68%-51.32M

-63.55%-15.09M

-70.25%-13.9M

-26.67%-10.5M

Investing cash flow

Cash flow from continuing investing activities

4.47%20.62M

123.77%52.54M

626.04%5.56M

124.08%15.27M

107.63%11.98M

4,666.43%19.73M

-311.95%-220.99M

97.89%-1.06M

-1,157.22%-63.39M

-627.63%-156.96M

Net PPE purchase and sale

-124.14%-195K

72.11%-256K

90.63%-27K

82.90%-53K

63.52%-89K

-14.47%-87K

40.31%-918K

18.64%-288K

67.98%-310K

-33.33%-244K

Net investment purchase and sale

5.00%20.81M

123.98%52.79M

826.82%5.58M

124.29%15.32M

107.70%12.07M

3,944.90%19.82M

-322.42%-220.11M

98.45%-768K

-1,448.33%-63.08M

-632.89%-156.75M

Net other investing changes

----

--39K

--0

----

Cash from discontinued investing activities

Investing cash flow

4.47%20.62M

123.77%52.54M

626.04%5.56M

124.08%15.27M

107.63%11.98M

4,666.43%19.73M

-311.95%-220.99M

97.89%-1.06M

-1,157.22%-63.39M

-627.63%-156.96M

Financing cash flow

Cash flow from continuing financing activities

20K

208.09%724K

285.38%501K

-91.39%13K

203.96%210K

-99.94%235K

-32.64%130K

403.33%151K

-4,140.00%-202K

Proceeds from stock option exercised by employees

--20K

9.37%724K

285.38%501K

-91.39%13K

-6.67%210K

--0

190.35%662K

-32.64%130K

403.33%151K

4,400.00%225K

Net other financing activities

----

---427K

--0

----

Cash from discontinued financing activities

Financing cash flow

--20K

208.09%724K

285.38%501K

-91.39%13K

203.96%210K

--0

-99.94%235K

-32.64%130K

403.33%151K

-4,140.00%-202K

Net cash flow

Beginning cash position

-20.00%21.2M

-91.12%26.5M

-34.28%27.94M

-77.27%27.2M

-89.97%28.81M

-91.12%26.5M

12,450.19%298.57M

-88.11%42.52M

-67.73%119.65M

-28.30%287.31M

Current changes in cash

255.00%8.2M

98.05%-5.3M

57.91%-6.74M

100.97%745K

99.04%-1.61M

120.51%2.31M

-191.86%-272.07M

72.90%-16.02M

-485.44%-77.14M

-461.57%-167.66M

End cash Position

2.04%29.4M

-20.00%21.2M

-34.28%27.94M

-77.27%27.2M

-89.97%28.81M

-91.12%26.5M

-88.11%42.52M

-67.73%119.65M

Free cash flow

27.85%-12.63M

-12.60%-58.82M

16.61%-12.83M

-2.66%-14.59M

-29.31%-13.89M

-47.11%-17.51M

-68.96%-52.24M

-60.52%-15.38M

-55.60%-14.21M

-26.82%-10.74M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	28.61%-12.44M	-14.11%-58.56M	15.19%-12.8M	-4.57%-14.53M	-31.47%-13.8M	-47.32%-17.42M	-74.68%-51.32M	-63.55%-15.09M	-70.25%-13.9M	-26.67%-10.5M
Net income from continuing operations	42.44%-11.11M	-5.61%-66.86M	31.71%-11.84M	10.82%-15.79M	-32.92%-19.94M	-45.45%-19.29M	-78.17%-63.31M	-56.71%-17.34M	-56.42%-17.7M	-96.42%-15M
Depreciation and amortization	10.85%143K	32.27%537K	11.29%138K	26.85%137K	44.57%133K	57.32%129K	214.73%406K	51.22%124K	248.39%108K	666.67%92K
Other non cash items	-60.00%4K	-48.44%33K	-54.55%5K	-42.86%8K	-60.00%10K	-28.57%10K	236.84%64K	-21.43%11K	--14K	--25K
Change In working capital	-430.56%-2.93M	-63.45%728K	-3,053.97%-1.99M	-131.52%-400K	101.21%3.67M	46.67%-553K	42.69%1.99M	-139.38%-63K	-31.41%1.27M	194.46%1.82M
-Change in prepaid assets	-134.48%-411K	158.18%1.97M	274.73%823K	66.40%-639K	175.58%598K	196.36%1.19M	-233.63%-3.39M	-334.33%-471K	-508.15%-1.9M	113.36%217K
-Change in payables and accrued expense	-44.58%-2.52M	-123.14%-1.25M	-788.73%-2.81M	-92.46%239K	91.16%3.07M	-972.50%-1.75M	123.17%5.39M	1,095.12%408K	129.12%3.17M	624.84%1.61M
Cash from discontinued investing activities
Operating cash flow	28.61%-12.44M	-14.11%-58.56M	15.19%-12.8M	-4.57%-14.53M	-31.47%-13.8M	-47.32%-17.42M	-74.68%-51.32M	-63.55%-15.09M	-70.25%-13.9M	-26.67%-10.5M
Investing cash flow
Cash flow from continuing investing activities	4.47%20.62M	123.77%52.54M	626.04%5.56M	124.08%15.27M	107.63%11.98M	4,666.43%19.73M	-311.95%-220.99M	97.89%-1.06M	-1,157.22%-63.39M	-627.63%-156.96M
Net PPE purchase and sale	-124.14%-195K	72.11%-256K	90.63%-27K	82.90%-53K	63.52%-89K	-14.47%-87K	40.31%-918K	18.64%-288K	67.98%-310K	-33.33%-244K
Net investment purchase and sale	5.00%20.81M	123.98%52.79M	826.82%5.58M	124.29%15.32M	107.70%12.07M	3,944.90%19.82M	-322.42%-220.11M	98.45%-768K	-1,448.33%-63.08M	-632.89%-156.75M
Net other investing changes	----	----	----	----	----	----	--39K	--0	--0	----
Cash from discontinued investing activities
Investing cash flow	4.47%20.62M	123.77%52.54M	626.04%5.56M	124.08%15.27M	107.63%11.98M	4,666.43%19.73M	-311.95%-220.99M	97.89%-1.06M	-1,157.22%-63.39M	-627.63%-156.96M
Financing cash flow
Cash flow from continuing financing activities	20K	208.09%724K	285.38%501K	-91.39%13K	203.96%210K	0	-99.94%235K	-32.64%130K	403.33%151K	-4,140.00%-202K
Proceeds from stock option exercised by employees	--20K	9.37%724K	285.38%501K	-91.39%13K	-6.67%210K	--0	190.35%662K	-32.64%130K	403.33%151K	4,400.00%225K
Net other financing activities	----	----	----	----	----	----	---427K	--0	--0	----
Cash from discontinued financing activities
Financing cash flow	--20K	208.09%724K	285.38%501K	-91.39%13K	203.96%210K	--0	-99.94%235K	-32.64%130K	403.33%151K	-4,140.00%-202K
Net cash flow
Beginning cash position	-20.00%21.2M	-91.12%26.5M	-34.28%27.94M	-77.27%27.2M	-89.97%28.81M	-91.12%26.5M	12,450.19%298.57M	-88.11%42.52M	-67.73%119.65M	-28.30%287.31M
Current changes in cash	255.00%8.2M	98.05%-5.3M	57.91%-6.74M	100.97%745K	99.04%-1.61M	120.51%2.31M	-191.86%-272.07M	72.90%-16.02M	-485.44%-77.14M	-461.57%-167.66M
End cash Position	2.04%29.4M	-20.00%21.2M	-20.00%21.2M	-34.28%27.94M	-77.27%27.2M	-89.97%28.81M	-91.12%26.5M	-91.12%26.5M	-88.11%42.52M	-67.73%119.65M
Free cash flow	27.85%-12.63M	-12.60%-58.82M	16.61%-12.83M	-2.66%-14.59M	-29.31%-13.89M	-47.11%-17.51M	-68.96%-52.24M	-60.52%-15.38M	-55.60%-14.21M	-26.82%-10.74M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall